Growth Metrics

Privia Health (PRVA) Cost of Revenue (2020 - 2026)

Privia Health has reported Cost of Revenue over the past 6 years, most recently at $6.4 million for Q4 2025.

  • For Q4 2025, Cost of Revenue changed 0.2% year-over-year to $6.4 million; the TTM value through Dec 2025 reached $27.1 million, up 2.61%, while the annual FY2025 figure was $27.1 million, 2.61% up from the prior year.
  • Cost of Revenue for Q4 2025 was $6.4 million at Privia Health, down from $7.0 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $11.2 million in Q2 2021 and troughed at $3.2 million in Q1 2021.
  • A 5-year average of $6.0 million and a median of $6.2 million in 2023 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: skyrocketed 403.51% in 2021 and later plummeted 56.89% in 2022.
  • Year by year, Cost of Revenue stood at $3.8 million in 2021, then surged by 36.13% to $5.2 million in 2022, then rose by 20.8% to $6.2 million in 2023, then grew by 3.41% to $6.5 million in 2024, then decreased by 0.2% to $6.4 million in 2025.
  • Business Quant data shows Cost of Revenue for PRVA at $6.4 million in Q4 2025, $7.0 million in Q3 2025, and $6.8 million in Q2 2025.